MedPath

Impact of fatty meal co-administration and dual-dosing on albendazole effectiveness against hookworm among school-aged children in Mayuge district, Uganda

Not Applicable
Conditions
Soil-transmitted helminth, hookworm infection
Registration Number
PACTR202202738940158
Lead Sponsor
World Vision Uganda
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
All
Target Recruitment
210
Inclusion Criteria

1)Children identified with hookworm infection in the January 2022 prevalence survey
2)Children attending randomly selected P4 and P5 classes in one of the randomly selected schools
3)Children whose parents/guardians provide written informed consent for the prevalence survey and for the nested trial if hookworm infection is detected.

Exclusion Criteria

1)Children who received benzimidazole drugs such as albendazole and mebendazole within three months before the prevalence survey to avoid the residual effect of previously administrated drugs of albendazole.
2)Children who have a history of allergic reaction to albendazole or other benzimidazole drugs such as mebendazole.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath